RecruitingNCT03546231
Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation
Clinical and Echocardiographic Characteristics and Prognosis of trIcuspid regurgiTation (EPIT): Prospective and Retrospective Follow-up of a Cohort of Patients With Moderate or Severe Tricuspid Regurgitation
Sponsor
Centre Hospitalier Universitaire, Amiens
Enrollment
400 participants
Start Date
Mar 15, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.
Eligibility
Min Age: 18 Months
Inclusion Criteria1
- Age >18 ans
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03546231
Related Trials
EFS of the DUO System for Tricuspid Regurgitation
NCT0591390815 locations
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT0409714579 locations
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
NCT0584828411 locations
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
NCT0726711715 locations
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
NCT0579751921 locations